Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,709 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Advances in Coronary Computed Tomographic Angiographic Imaging of Atherosclerosis for Risk Stratification and Preventive Care.
Bienstock S, Lin F, Blankstein R, Leipsic J, Cardoso R, Ahmadi A, Gelijns A, Patel K, Baldassarre LA, Hadley M, LaRocca G, Sanz J, Narula J, Chandrashekhar YS, Shaw LJ, Fuster V. Bienstock S, et al. Among authors: sanz j. JACC Cardiovasc Imaging. 2023 Aug;16(8):1099-1115. doi: 10.1016/j.jcmg.2023.02.002. Epub 2023 May 10. JACC Cardiovasc Imaging. 2023. PMID: 37178070 Review.
Validation of American Society of Echocardiography Guideline-Recommended Parameters of Right Ventricular Dysfunction Using Artificial Intelligence Compared With Cardiac Magnetic Resonance Imaging.
Hsia BC, Lai A, Singh S, Samtani R, Bienstock S, Liao S, Stern E, LaRocca G, Sanz J, Lerakis S, Croft L, Carrasso S, Rosenmann D, DeMaria A, Stone GW, Goldman ME. Hsia BC, et al. Among authors: sanz j. J Am Soc Echocardiogr. 2023 Sep;36(9):967-977. doi: 10.1016/j.echo.2023.05.015. Epub 2023 Jun 17. J Am Soc Echocardiogr. 2023. PMID: 37331608
Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes.
Pérez MS, Rodríguez-Capitán J, Requena-Ibáñez JA, Santos-Gallego CG, Urooj Zafar M, Escolar G, Mancini D, Mitter S, Lam D, Contreras JP, Fergus I, Atallah-Lajam F, Abascal V, Lala A, Moreno P, Moss N, Lerakis S, Sanz J, Fuster V, Badimon JJ. Pérez MS, et al. Among authors: sanz j. Cardiovasc Drugs Ther. 2023 Jun 15. doi: 10.1007/s10557-023-07469-6. Online ahead of print. Cardiovasc Drugs Ther. 2023. PMID: 37318685
Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis.
Devesa A, Fuster V, Vazirani R, García-Lunar I, Oliva B, España S, Moreno-Arciniegas A, Sanz J, Perez-Herreras C, Bueno H, Lara-Pezzi E, García-Alvarez A, de Vega VM, Fernández-Friera L, Trivieri MG, Fernández-Ortiz A, Rossello X, Sanchez-Gonzalez J, Ibanez B. Devesa A, et al. Among authors: sanz j. Diabetes Care. 2023 Nov 1;46(11):2050-2057. doi: 10.2337/dc23-0871. Diabetes Care. 2023. PMID: 37713581 Free PMC article.
PTCy versus CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin Lymphoma: a study of the LWP of the EBMT.
Montoro J, Ngoya M, Kulagin A, Giebel S, Broers AEC, Bramanti S, Halahleh K, Perez-Simon JA, Solano C, Ozcelik T, Blaise D, Sanz J, Henriques M, Peffault de Latour R, Martino R, Scheid C, Fox L, Gromek T, Jurado M, Sakellari I, van Gorkom G, Matteucci P, Nagler A, Koc Y, Glass B. Montoro J, et al. Among authors: sanz j. Blood Adv. 2024 May 29:bloodadvances.2024013328. doi: 10.1182/bloodadvances.2024013328. Online ahead of print. Blood Adv. 2024. PMID: 38810260
1,709 results